Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - rabeprazole sodium - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; rabeprazole - alimentary tract and metabolism, drugs for peptic ulcer and gastro-oesophageal reflux disease (gord), proton pump inhibitors - it is indicated in:
active duodenal ulcer;
active benign gastric ulcer;
symptomatic erosive or ulcerative gastro-oesophageal reflux disease (gord);
gastro-oesophageal reflux disease, long-term management (gord maintenance);
symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic gord)
zollinger-ellison syndrome;
in combination with appropriate antibacterial therapeutic regimens for the eradication of helicobacter pylori in patients with peptic ulcer disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - pantoprazole - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - pantoprazole - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - fexofenadine hydrochloride - film-coated tablet - fexofenadine

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - risankizumab - solution for injection - risankizumab 75 mg / 0.83 ml - risankizumab - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of activepsoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards).

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - risankizumab - solution for injection - risankizumab 150 mg / 1 ml - risankizumab - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of activepsoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards).

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - acetylsalicylic acid; pseudoephedrine hydrochloride - granules for oral suspension - 500/30 milligram(s) - salicylic acid and derivatives; acetylsalicylic acid, combinations excl. psycholeptics

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - letrozole - film-coated tablet - 2.5 milligram(s) - aromatase inhibitors; letrozole

Philippines - English - FDA (Food And Drug Administration)

new marketlink pharmaceutical corporation; distributor: metro drug, inc. - pinene (alpha & beta); camphene; cineol; menthol; menthone; borneol; olive oil - capsule - 17 mg; 5 mg; 2 mg; 32 mg; 6 mg; 5 mg; 33 mg